Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, et al: A review of human carcinogens-Part B: biological agents. Lancet Oncol. 10:321–322. 2009. View Article : Google Scholar : PubMed/NCBI

Muñoz N, Castellsagué X, Berrington de González A and Gissmann L: Chapter 1: HPV in the etiology of human cancer. Vaccine. 24(Suppl 3): S1–S10. 2006. View Article : Google Scholar

Bialecki ES and Di Bisceglie AM: Clinical presentation and natural course of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 17:485–489. 2005. View Article : Google Scholar : PubMed/NCBI

Hermine O, Lefrère F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, et al: Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 347:89–94. 2002. View Article : Google Scholar : PubMed/NCBI

Thompson MP and Kurzrock R: Epstein-Barr virus and cancer. Clin Cancer Res. 10:803–821. 2004. View Article : Google Scholar : PubMed/NCBI

Mesri EA, Feitelson MA and Munger K: Human viral oncogenesis: A cancer hallmarks analysis. Cell Host Microbe. 15:266–282. 2014. View Article : Google Scholar : PubMed/NCBI

Medina-Ortega AP, López-Valencia D, Mosquera-Monje SL, Mora-Obando DL and Dueñas-Cuéllar RA: Relationship between Epstein-Barr virus and cancer development. Iatreia. 30:131–145. 2017. View Article : Google Scholar

Pietropaolo V, Prezioso C and Moens U: Role of virus-induced host cell epigenetic changes in cancer. Int J Mol Sci. 22:83462021. View Article : Google Scholar : PubMed/NCBI

Hulse M, Caruso LB, Madzo J, Tan Y, Johnson S and Tempera I: Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1. PLoS Pathog. 4:e10073942018. View Article : Google Scholar

Cao Y, Xie L, Shi F, Tang M, Li Y, Hu J, Zhao L, Zhao L, Yu X, Luo X, et al: Targeting the signaling in Epstein-Barr virus-associated diseases: Mechanism, regulation, and clinical study. Signal Transduct Target Ther. 6:152021. View Article : Google Scholar : PubMed/NCBI

He B, Li W, Wu Y, Wei F, Gong Z, Bo H, Wang Y, Li X, Xiang B, Guo C, et al: Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103. Cell Death Dis. 7:e23532016. View Article : Google Scholar : PubMed/NCBI

Hechter O, Sausen DG, Gallo ES, Dahari H and Borenstein R: Epstein-Barr virus (EBV) epithelial associated malignancies: Exploring pathologies and current treatments. Int J Mol Sci. 23:143892022. View Article : Google Scholar

Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, Ji X, Liu W, Huang B, Luo W, et al: Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 5:77–106. 2018. View Article : Google Scholar : PubMed/NCBI

Wang M, Yu F, Wu W, Wang Y, Ding H and Qian L: Epstein-Barr virus-encoded microRNAs as regulators in host immune responses. Int J Biol Sci. 14:565–576. 2018. View Article : Google Scholar : PubMed/NCBI

El-Sharkawy A, Al Zaidan L and Malki A: Epstein-Barr virus-associated malignancies: Roles of viral oncoproteins in carcinogenesis. Front Oncol. 8:2652018. View Article : Google Scholar : PubMed/NCBI

Shannon-Lowe C, Adland E, Bell A, Delecluse H, Rickinson A and Rowe M: Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol. 83:7749–7760. 2009. View Article : Google Scholar : PubMed/NCBI

Sinclair AJ, Moalwi MH and Amoaten T: Is EBV associated with breast cancer in specific geographic locations? Cancers (Basel). 13:8192021. View Article : Google Scholar : PubMed/NCBI

Shannon-Lowe C and Rowe M: Epstein Barr virus entry; kissing and conjugation. Curr Opin Virol. 4:78–84. 2014. View Article : Google Scholar : PubMed/NCBI

Shannon-Lowe C and Rowe M: Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection. PLoS Pathog. 7:e10013382011. View Article : Google Scholar : PubMed/NCBI

Imai S, Nishikawa J and Takada K: Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol. 72:4371–4378. 1998. View Article : Google Scholar : PubMed/NCBI

Tugizov SM, Berline JW and Palefsky JM: Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med. 9:307–314. 2003. View Article : Google Scholar : PubMed/NCBI

Chen J, Sathiyamoorthy K, Zhang X, Schaller S, Perez White BE, Jardetzky TS and Longnecker R: Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus. Nat Microbiol. 3:172–180. 2018. View Article : Google Scholar : PubMed/NCBI

Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX, Dong XD, Li SB, Du Y, Xiong D, et al: Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry. Nat Microbiol. 3:164–171. 2018.

Ayee R, Ofori MEO, Wright E and Quaye O: Epstein Barr Virus associated lymphomas and epithelia cancers in humans. J Cancer. 11:1737–1750. 2020. View Article : Google Scholar : PubMed/NCBI

Al Moustafa AE, Al-Antary N, Aboulkassim T, Akil N, Batist G and Yasmeen A: Co-prevalence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian women with breast cancer. Hum Vaccin Immunother. 12:1936–1939. 2016.PubMed/NCBI

Lin JH, Tsai CH, Chu JS, Chen JY, Takada K and Shew JY: Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells. J Virol. 81:5705–5713. 2007. View Article : Google Scholar : PubMed/NCBI

Pal AD, Basak NP, Banerjee AS and Banerjee S: Epstein-Barr virus latent membrane protein-2A alters mitochondrial dynamics promoting cellular migration mediated by Notch signaling pathway. Carcinogenesis. 35:1592–1601. 2014. View Article : Google Scholar : PubMed/NCBI

Arias-Calvachi C, Blanco R, Calaf GM and Aguayo F: Epstein-Barr virus association with breast cancer: Evidence and perspectives. Biology (Basel). 11:7992022.PubMed/NCBI

Nasser F, Moussa N, Helmy MW and Haroun M: Dual targeting of Notch and Wnt/β-catenin pathways: Potential approach in triple-negative breast cancer treatment. Naunyn Schmiedebergs Arch Pharmacol. 394:481–490. 2021. View Article : Google Scholar

Gómez-Archila JD, Espinosa-García AM, Palacios-Reyes C, Trujillo-Cabrera Y, Mejía ALS, González AVA, Rangel-López E, Alonso-Themann PG, Solís NDS, Hernández-Zavala A, et al: NOTCH expression variability and relapse of breast cancer in high-risk groups. Am J Med Sci. 364:583–594. 2022. View Article : Google Scholar : PubMed/NCBI

Shahi V, Agarwal P, Qayoom S, Kumar V, Tewari S, Raghuvanshi S, Singh US and Goel MM: Detection of Epstein Barr nuclear antigen-1 (EBNA-1), early antigen 1F, 2R (EA-1F, EA-2R) along with Epstein-Barr virus latent membrane protein 1 (LMP1) in breast cancer of Northern India: An interim analysis. Asian Pac J Cancer Prev. 23:3717–3723. 2022. View Article : Google Scholar : PubMed/NCBI

Wang Z, Li Z, Wu Q, Li C, Li J, Zhang Y, Wang C and Sun S and Sun S: DNER promotes epithelial-mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer. Cell Death Dis. 11:6422020. View Article : Google Scholar

Zimber-Strobl U and Strobl LJ: EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin Cancer Biol. 11:423–434. 2001. View Article : Google Scholar : PubMed/NCBI

Anderson L and Longnecker R: An auto-regulatory loop for EBV LMP2A involves activation of Notch. Virology. 371:257–266. 2008. View Article : Google Scholar

Cyprian FS, Al-Farsi HF, Vranic S, Akhtar S and Al Moustafa AE: Epstein-Barr virus and human papillomaviruses interactions and their roles in the initiation of epithelial-mesenchymal transition and cancer progression. Front Oncol. 8:1112018. View Article : Google Scholar : PubMed/NCBI

Zanella L, Riquelm I, Buchegger K, Abanto M, Ili C and Brebi P: A reliable Epstein-Barr virus classification based on phylogenomic and population analyses. Sci Rep. 9:98292019. View Article : Google Scholar : PubMed/NCBI

Zimber U, Adldinger HK, Lenoir GM, Vuillaume M, Knebel-Doeberitz MV, Laux G, Desgranges C, Wittmann P, Freese UK, Schneider U, et al: Geographical prevalence of two types of Epstein-Barr virus. Virology. 154:56–66. 1986. View Article : Google Scholar : PubMed/NCBI

Smith NA, Baresel PC, Jackson CL, Ogolla S, Toko EN, Heit S, Piriou E, Sumba OP, Middeldorp JM, Colborn KL and Rochford R: Differences in the Epstein-Barr virus gp350 IgA antibody response are associated with increased risk for coinfection with a second strain of Epstein-Barr virus. J Infect Dis. 219:955–963. 2019. View Article : Google Scholar :

Lung ML, Li SB and Chang RS: Study of Epstein-Barr virus (EBV) transmission by EBV genotyping. J Infect Dis. 164:213–214. 1991. View Article : Google Scholar : PubMed/NCBI

Golrokh Mofrad M, Kazeminezhad B and Faghihloo E: Prevalence of Epstein-Barr virus (EBV) in Iranian breast carcinoma patients. Asian Pac J Cancer Prev. 21:133–137. 2020. View Article : Google Scholar : PubMed/NCBI

Gupta I, Jabeen A, Al-Sarraf R, Farghaly H, Vranic S, Sultan AA, Al Moustafa AE and Al-Thawadi H: The co-presence of high-risk human papillomaviruses and Epstein-Barr virus is linked with tumor grade and stage in Qatari women with breast cancer. Hum Vaccin Immunother. 17:982–989. 2021. View Article : Google Scholar :

Aboulkassim T, Yasmeen A, Akil N, Batist G and Al Moustafa AE: Incidence of Epstein-Barr virus in Syrian women with breast cancer: A tissue microarray study. Hum Vaccin Immunother. 11:951–955. 2015. View Article : Google Scholar : PubMed/NCBI

Fessahaye G, Elhassan AM, Elamin EM, Adam AAM, Ghebremedhin A and Ibrahim ME: Association of Epstein-Barr virus and breast cancer in Eritrea. Infect Agents Cancer. 12:622017. View Article : Google Scholar

Nwagu GC, Bhattarai S, Swahn M, Ahmed S and Aneja R: Prevalence and mortality of triple-negative breast cancer in West Africa: Biologic and sociocultural factors. JCO Glob Oncol. 7:1129–1140. 2021. View Article : Google Scholar : PubMed/NCBI

Acheampong T, Kehm RD, Terry MB, Argov EL and Tehranifar P: Incidence trends of breast cancer molecular subtypes by age and race/ethnicity in the US from 2010 to 2016. JAMA Netw Open. 3:e20132262020. View Article : Google Scholar : PubMed/NCBI

Siddharth S and Sharma D: Racial disparity and triple-negative breast cancer in African-American women: A multifaceted affair between obesity, biology, and socioeconomic determinants. Cancers (Basel). 10:5142018. View Article : Google Scholar : PubMed/NCBI

Ibrahim SA, Hassan H, Vilardo L, Kumar SK, Kumar AV, Kelsch R, Schneider C, Kiesel L, Eich HT, Zucchi I, et al: Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling. PLoS One. 8:e857372013. View Article : Google Scholar

Rahim A, Afzal M and Naveed AK: Genetic polymorphism of miRNA-196a and its target gene annexin-A1 expression based on ethnicity in Pakistani female breast cancer patients. Pak J Med Sci. 35:1598–1604. 2019. View Article : Google Scholar : PubMed/NCBI

Treece AL, Duncan DL, Tang W, Elmore S, Morgan DR and Gulley ML, Speck O, Meyers MO and Gulley ML: Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns. Lab Invest. 96:661–671. 2016. View Article : Google Scholar : PubMed/NCBI

Ramanto KN, Widianto KJ, Wibowo SSH and Agustriawan D: The regulation of microRNA in each of cancer stage from two different ethnicities as potential biomarker for breast cancer. Comput Biol Chem. 93:1074972021. View Article : Google Scholar : PubMed/NCBI

GLOBOCAN 2020: International Agency for Research of Cancer 2022. Available in: http://gco.iarc.fr/. Accessed May 5, 2022

Mexican consensus on diagnosis and breast cancer treatment. GAMO. 7(Supl 2)2021. View Article : Google Scholar

Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H and Nasrallah GK: Epstein-Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: An update. Front Oncol. 8:2112018. View Article : Google Scholar : PubMed/NCBI

Fierti AO, Yakass MB, Okertchiri EA, Adadey SM and Quay O: The role of Epstein-Barr virus in modulating key tumor suppressor genes in associated malignancies: Epigenetics, transcriptional, and post-translational modifications. Biomolecules. 12:1272022. View Article : Google Scholar : PubMed/NCBI

Mátyási B, Farkas Z, Kopper L, Sebestyén A, Boissan M, Mehta A and Takács-Vellai K: The function of NM23-H1/NME1 and its homologs in major processes linked to metastasis. Pathol Oncol Res. 26:49–61. 2020. View Article : Google Scholar : PubMed/NCBI

Cheerathodi MR and Meckes DG Jr: The Epstein-Barr virus LMP1 interactome: Biological implications and therapeutic targets. Future Virol. 13:863–887. 2018. View Article : Google Scholar : PubMed/NCBI

Longnecker R and Kieff E: A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J Virol. 64:2319–2326. 1990. View Article : Google Scholar : PubMed/NCBI

Wasil LR and Shair KHY: Modified anoikis assay that functionally segregates Epstein-Barr virus LMP1 strains into two groups. J Virol. 92:e00557–18. 2018. View Article : Google Scholar : PubMed/NCBI

Xie L, Shi F, Li Y, Li W, Yu X, Zhao L, Zhou M, Hu J, Luo X, Tang M, et al: Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance. Signal Transduct Target Ther. 5:562020. View Article : Google Scholar : PubMed/NCBI

Pratt ZL, Kuzembayeva M, Sengupta S and Sugden B: The microRNAs of Epstein-Barr virus are expressed at dramatically differing levels among cell lines. Virology. 386:387–397. 2009. View Article : Google Scholar : PubMed/NCBI

Wang M, Gu B, Chen X, Wang Y, Li P and Wang K: The function and therapeutic potential of Epstein-Barr virus-encoded MicroRNAs in cancer. Mol Ther Nucleic Acids. 17:657–668. 2019. View Article : Google Scholar : PubMed/NCBI

Liu Y, Hu Z, Zhang Y and Wang C: Long non-coding RNAs in Epstein-Barr virus-related cancer. Cancer Cell Int. 21:2782021. View Article : Google Scholar : PubMed/NCBI

Kang MS and Kieff E: Epstein-Barr virus latent genes. Exp Mol Med. 47:e1312015. View Article : Google Scholar : PubMed/NCBI

Houmani JL, Davis CI and Ruf IK: Growth-promoting properties of Epstein-Barr virus EBER-1 RNA correlate with ribosomal protein L22 binding. J Virol. 83:9844–9853. 2009. View Article : Google Scholar : PubMed/NCBI

Samanta M, Iwakiri D, Kanda T, Imaizumi T and Takada K: EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 25:4207–4214. 2006. View Article : Google Scholar : PubMed/NCBI

Yang GD, Huang TJ, Peng LX, Yang CF, Liu RY, Huang HB, Chu QQ, Yang HJ, Huang JL, Zhu ZY, et al: Epstein-Barr virus_encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced apoptosis by suppressing PDCD4 and Fas-L. PLoS One. 8:e783552013. View Article : Google Scholar : PubMed/NCBI

Sales ACV, Gomes da Silva IIF, Leite MCB, Coutinho LL, Reis RBAC, Castoldi A, Bg Martins D, Lima-Filho JL and Souto FO: Mirna21 expression in the breast cancer tumor tissue is independent of neoadjuvant chemotherapy. Breast Cancer (Dove Med Press). 12:141–151. 2020.PubMed/NCBI

Zhu K, Wu Y, He P, Fan Y, Zhong X, Zheng H and Luo T: PI3K/AKT/mTOR-targeted therapy for breast cancer. Cells. 11:25082022. View Article : Google Scholar : PubMed/NCBI

Tankova T, Senkus E, Beloyartseva M, Borštnar S, Catrinoiu D, Frolova M, Hegmane A, Janež A, Krnić M, Lengyel Z, et al: Management strategies for hyperglycemia associated with the α-selective PI3K inhibitor alpelisib for the treatment of breast cancer. Cancers (Basel). 14:15982022. View Article : Google Scholar

Mostafaei S, Kazemnejad A, Norooznezhad AH, Mahaki B and Moghoofei M: Simultaneous effects of viral factors of human papilloma virus and Epstein-Barr virus on progression of breast and thyroid cancers: Application of structural equation modeling. Asian Pac J Cancer Prev. 21:1431–1439. 2020. View Article : Google Scholar : PubMed/NCBI

Tsai JH, Tsai CH, Cheng MH, Lin SJ, Xu FL and Yang CC: Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol. 75:276–281. 2005. View Article : Google Scholar

Tsai JH, Hsu CS, Tsai CH, Su JM, Liu YT, Cheng MH, Wei JC, Chen FL and Yang CC: Relationship between viral factors, axillary lymph node status and survival in breast cancer. J Cancer Res Clin Oncol. 133:13–21. 2007. View Article : Google Scholar

Klein G: Tumor associations of EBV-historical perspectives. Curr Top Microbiol Immunol. 390:17–22. 2015.

Yates J, Warren N, Reisman D and Sugden B: A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USa. 81:3806–3810. 1984. View Article : Google Scholar : PubMed/NCBI

Naushad W, Surriya O and Sadia H: Prevalence of EBV, HPV and MMTV in Pakistani breast cancer patients: A possible etiological role of viruses in breast cancer. Infect Genet Evol. 54:230–237. 2017. View Article : Google Scholar : PubMed/NCBI

Corbex M, Bouzbid S, Traverse-Glehen A, Aouras H, McKay-Chopin S, Carreira C, Lankar A, Tommasino M and Gheit T: Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from Algeria compared with other types of breast cancer tumors. PLoS One. 9:e1145592014. View Article : Google Scholar : PubMed/NCBI

McKenzie J and El-Guindy A: Epstein-Barr virus lytic cycle reactivation. Curr Top Microbiol Immunol. 391:237–261. 2015.PubMed/NCBI

Murata T, Sugimoto A, Inagaki T, Yanagi Y, Watanabe T, Sato Y and Kimura H: Molecular basis of Epstein-Barr virus latency establishment and lytic reactivation. Viruses. 13:23442021. View Article : Google Scholar : PubMed/NCBI

Chéne A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, Falk KI, Orem J, Kironde F, Wahlgren M and Bejarano MT: A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog. 3:e802007. View Article : Google Scholar : PubMed/NCBI

Gold JE, Okyay RA, Licht WE and Hurley DJ: Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens. 10:7632021. View Article : Google Scholar : PubMed/NCBI

Hu J, Li Y, Li H, Shi F, Xie L, Zhao L, Tang M, Luo X, Jia W, Fan J, et al: Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy. Theranostics. 10:11921–11937. 2020. View Article : Google Scholar : PubMed/NCBI

Mehta SK, Bloom DC, Plante I, Stowe R, Feiveson AH, Renner A, Dhummakupt A, Markan D, Zhang Y, Wu H, et al: Reactivation of latent Epstein-Barr virus: A comparison after exposure to gamma, proton, carbon, and iron radiation. Int J Mol Sci. 19:29612018. View Article : Google Scholar : PubMed/NCBI

Sausen DG, Bhutta MS, Gallo ES, Dahari H and Borenstein R: Stress-induced Epstein-Barr virus reactivation. Biomolecules. 11:13802021. View Article : Google Scholar : PubMed/NCBI

Anderson NM and Simon MC: The tumor microenvironment. Curr Biol. 30:R921–R925. 2020. View Article : Google Scholar : PubMed/NCBI

Kluwe J, Mencin A and Schwabe RF: Toll-like receptors, wound healing, and carcinogenesis. J Mol Med (Berl). 87:125–138. 2009. View Article : Google Scholar

Pedroza-Gonzalez A, Xu K, Wu TC, Aspord C, Tindle S, Marches F, Gallegos M, Burton EC, Savino D, Hori T, et al: Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med. 208:479–490. 2011. View Article : Google Scholar : PubMed/NCBI

DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N and Coussens LM: CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell. 16:91–102. 2009. View Article : Google Scholar : PubMed/NCBI

Kuan EL and Ziegler SF: A tumor-myeloid cell axis, mediated via the cytokines IL-1α and TSLP, promotes the progression of breast cancer. Nat Immunol. 19:366–374. 2018. View Article : Google Scholar : PubMed/NCBI

Wu TC, Xu K, Martinek J, Young RR, Banchereau R, George J, Turner J, Kim KI, Zurawski S, Wang X, et al: IL1 receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer. Cancer Res. 78:5243–5258. 2018. View Article : Google Scholar : PubMed/NCBI

Sheikhpour E, Noorbakhsh P, Foroughi E, Farahnak S, Nasiri R and Neamatzadeh H: A survey on the role of interleukin-10 in breast cancer: A narrative. Rep Biochem Mol Biol. 7:30–37. 2018.PubMed/NCBI

Azuma K, Ikeda K, Suzuki T, Aogi K, Horie-Inoue K and Inoue S: TRIM47 activates NF-κB signaling via PKC-ε/PKD3 stabilization and contributes to endocrine therapy resistance in breast cancer. Proc Natl Acad Sci USA. 118:e21007841182021. View Article : Google Scholar

Omokehinde T and Johnson RW: GP130 cytokines in breast cancer and bone. Cancers (Basel). 12:3262020. View Article : Google Scholar : PubMed/NCBI

Wang L, Simons DL, Lu X, Tu TY, Avalos C, Chang AY, Dirbas FM, Yim JH, Waisman J and Lee PP: Breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes. EBioMedicine. 52:1026312020. View Article : Google Scholar : PubMed/NCBI

Crake RLI, Strother MR, Phillips E, Doogue MP, Zhang M, Frampton CMA, Robinson BA and Currie MJ: Influence of serum inflammatory cytokines on cytochrome P450 drug metabolising activity during breast cancer chemotherapy: A patient feasibility study. Sci Rep. 11:56482021. View Article : Google Scholar : PubMed/NCBI

Sparano JA, O'Neill A, Graham N, Northfelt DW, Dang CT, Wolff AC, Sledge GW and Miller KD: Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer. NPJ Breast Cancer. 8:162022. View Article : Google Scholar : PubMed/NCBI

Chen W, Qin Y and Liu S: Cytokines, breast cancer stem cells (BCSCs) and chemoresistance. Clin Transl Med. 7:272018. View Article : Google Scholar : PubMed/NCBI

Liu F, Li L, Lan M, Zou T, Kong Z, Cai T, Wu XY and Cai Y: Key factor regulating inflammatory microenvironment, metastasis, and resistance in breast cancer: Interleukin-1 signaling. Mediators Inflamm. 2021:77858902021. View Article : Google Scholar : PubMed/NCBI

Cierna Z, Smolkova B, Cholujova D, Gronesova P, Miklikova S, Cihova M, Plava J and Mego M: Decreased levels of circulating cytokines VEGF, TNF-β and IL-15 indicate PD-L1 overexpression in tumours of primary breast cancer patients. Sci Rep. 11:12942021. View Article : Google Scholar

Figenschau SL, Knutsen E, Urbarova I, Fenton C, Elston B, Perander M, Mortensen ES and Fenton KA: ICAM1 expression is induced by proinflammatory cytokines and associated with TLS formation in aggressive breast cancer subtypes. Sci Rep. 8:117202018. View Article : Google Scholar : PubMed/NCBI

Jurisic V: Multiomic analysis of cytokines in immuno-oncology. Expert Rev Proteomics. 17:663–674. 2020. View Article : Google Scholar : PubMed/NCBI

Farahmand M, Monavari SH, Shoja Z, Ghaffari H, Tavakoli M and Tavakoli A: Epstein-Barr virus and risk of breast cancer: A systematic review and meta-analysis. Future Oncol. 15:2873–2885. 2019. View Article : Google Scholar : PubMed/NCBI

Jin Q, Su J, Yan D and Wu S: Epstein-Barr virus infection and increased sporadic breast carcinoma risk: A meta-analysis. Med Princ Pract. 29:195–200. 2020. View Article : Google Scholar :

Morales-Sánchez A, Molina-Muñoz T, Martínez-López JL, Hernández-Sancén P, Mantilla A, Leal YA, Torres J and Fuentes-Pananá EM: No association between Epstein-Barr virus and mouse mammary tumor virus with breast cancer in Mexican women. Sci Rep. 3:29702013. View Article : Google Scholar : PubMed/NCBI

Palser AL, Grayson NE, White RE, Corton C, Correia S, Ba Abdullah MM, Watson SJ, Cotton M, Arrand JR, Murray PG, et al: Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection. J Virol. 89:5222–5237. 2015. View Article : Google Scholar : PubMed/NCBI

Ba Abdullah MM, Palermo RD, Palser AL, Grayson NE, Kellam P, Correia S, Szymula A and White RE: Heterogeneity of the Epstein-Barr virus (EBV) major internal repeat reveals evolutionary mechanisms of EBV and a functional defect in the prototype EBV strain B95-8. J Virol. 91:e00920–17. 2017. View Article : Google Scholar : PubMed/NCBI

Farrell PJ and White RE: Do Epstein-Barr virus mutations and natural genome sequence variations contribute to disease? Biomolecules. 12:172021. View Article : Google Scholar